White Paper

Infectious Disease Challenge Studies: Ethical Issues In Causing Disease For Medical Knowledge

Source: WCG

By Daniel Kavanagh, Ph.D., Currien MacDonald, MD, CIP, Lindsay McNair, MD, MPH, MSB

Infectious disease “challenge” studies, in which healthy participants are deliberately infected with pathogens to investigate the cause, prevention, and treatment of infectious diseases, hold great potential for delivering high-quality data about new interventions. Infectious challenge studies may be used to address a variety of scientific questions, such as demonstrating a causative role for a specific infectious agent in a particular disease, testing the ability of a drug to prevent or ameliorate disease, or testing the efficacy of a prophylactic vaccine.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader